Citi Pharma partners with Mersi Farma to boost API manufacturing

News Image

MG News | December 03, 2024 at 02:02 PM GMT+05:00

0:00

December 03, 2024 (MLN): Citi Pharma Limited (PSX: CPHL) has forged a strategic partnership with Mersi Farma, an Indonesia-based Based Leading Pharmaceutical Company, to Advance Active Pharmaceutical Ingredient (API) Manufacturing and Expand the Nutraceutical Market in Indonesia.

The company has signed a Memorandum of Understanding (MoU) with Mersi Farma, marking a transformative collaboration to establish API  manufacturing facilities and expand nutraceutical product accessibility in Indonesia.

Key Provisions of the Partnership:

1. Development of Advanced API Manufacturing Facilities

  • Paracetamol API Plant: A state-of-the-art facility with an annual production capacity of 10,000 metric tons per annum.
  • Amoxicillin API Plant: A high-capacity plant with an annual production capacity of 1,800 metric tons per annum. These facilities will meet Pharmaceutical Inspection Co-operation Scheme (PICTS) compliance standards, ensuring the highest quality production processes.

The Paracetamol and Amoxicillin plants will be the first large-scale API manufacturing facilities in Indonesia, significantly reducing the country's dependence on imported APIs.

This strategic initiative aims to bolster local production capacity, enhance self-reliance and contribute to Indonesia's healthcare infrastructure.

2. Joint Investment and Expertise Deployment

  • Citi Pharma Limited will provide substantial capital investment and integrate state-of-the-art technology to establish world-class production capabilities.
  • Mersi Farma will co-invest and utilize its extensive operational network within Indonesia to oversee operations and optimize market distribution for APIs.

3. Nutraceutical Market Penetration in Indonesia

  • Citi Pharma Limited will introduce its premium nutraceutical product range, catering to the growing demand for health and wellness solutions.
  • Mersi Farma will manage the marketing, sales and distribution of these products through its robust and well-established local distribution framework.

4. Strategic Implications

This partnership is a cornerstone of shared efforts to:

  • Drive innovation in the pharmaceutical and nutraceutical sectors.
  • Enhance regional healthcare accessibility through localized and high-quality API manufacturing.
  • Promote economic sustainability by reducing Indonesia's reliance on API imports and fostering local industrial growth.

With the first bulk API manufacturing plant in Indonesia, this collaboration represents a pivotal shift toward self-sufficiency and technological advancement in the country's healthcare landscape.

Looking Ahead

Citi Pharma Limited and Mersi Farina are dedicated to making this partnership a model of excellence in pharmaceutical production and distribution.

Copyright Mettis Link News

Related News

Name Price/Vol %Chg/NChg
KSE100 159,034.65
128.70M
0.36%
569.59
ALLSHR 97,073.77
313.52M
0.53%
514.61
KSE30 48,413.66
73.67M
0.16%
78.74
KMI30 230,165.75
53.67M
0.48%
1110.40
KMIALLSHR 63,638.31
154.89M
0.63%
398.95
BKTi 44,448.41
20.69M
-0.41%
-183.87
OGTi 31,476.60
1.64M
0.58%
180.84
Symbol Bid/Ask High/Low
Name Last High/Low Chg/%Chg
BITCOIN FUTURES 110,280.00 111,595.00
108,025.00
-350.00
-0.32%
BRENT CRUDE 64.51 64.96
64.51
-0.41
-0.63%
RICHARDS BAY COAL MONTHLY 80.50 0.00
0.00
-1.10
-1.35%
ROTTERDAM COAL MONTHLY 92.50 0.00
0.00
-0.20
-0.22%
USD RBD PALM OLEIN 1,082.50 1,082.50
1,082.50
0.00
0.00%
CRUDE OIL - WTI 60.10 60.47
59.96
-0.38
-0.63%
SUGAR #11 WORLD 14.43 14.56
14.21
0.06
0.42%

Chart of the Day


Latest News
October 30, 2025 at 11:06 AM GMT+05:00

Clover Pakistan's 1QFY26 profit plunges 67%


October 30, 2025 at 10:46 AM GMT+05:00

TPL Trakker's 1QFY26 loss nearly doubles


October 30, 2025 at 10:45 AM GMT+05:00

PREMA's bottom line turns creamy



Top 5 things to watch in this week

Pakistan Stock Movers
Name Last Chg/%Chg
Name Last Chg/%Chg